Cefepime, a fourth-generation cephalosporin, in complex with manganese, inhibits proteasome activity and induces the apoptosis of human breast cancer cells
Open Access
- 30 July 2015
- journal article
- Published by Spandidos Publications in International Journal of Molecular Medicine
- Vol. 36 (4) , 1143-1150
Abstract
Cefepime (FEP), which is a member of the fourth-generation cephalosporin class, has been extensively studied as a biochemical and antimicrobial reagent in recent years. Manganese (Mn) is important in the biochemical and physiological processes of many living organisms, and it is also high expressed in some tumor tissues. In the present study, we aimed to investigate the proteasome-inhibitory and anti-proliferative properties of 8 metal complexes (FEP‑Cu, FEP-Zn, FEP-Co, FEP-Ni, FEP-Cd, FEP-Cr, FEP-Fe, FEP-Mn) in MDA-MB‑231 human breast cancer cells. The FEP-Mn complex was found to be more potent in its ability to inhibit cell proliferation and proteasome activity than the other compounds tested. Moreover, the FEP-Mn complex inhibited proteasomal chymotrypsin-like (CT-like) activity and induced the apoptosis of breast cancer cells in a dose-and time-dependent manner. Furthermore, the MCF-10A cells were much less sensitive to the FEP complexes compared with the MDA-MB-231 breast cancer cells. These results demonstrated that the FEP-Mn(II) complex has the potential to act as a proteasome inhibitor and apoptosis inducer and therefore has possible future applications in cancer chemotherapy.Keywords
This publication has 49 references indexed in Scilit:
- Organic cadmium complexes as proteasome inhibitors and apoptosis inducers in human breast cancer cellsJournal of Inorganic Biochemistry, 2013
- 1,10-Phenanthroline promotes copper complexes into tumor cells and induces apoptosis by inhibiting the proteasome activityJBIC Journal of Biological Inorganic Chemistry, 2012
- Anticancer Activity, Attenuation on the Absorption of Calcium in Mitochondria, and Catalase Activity for Manganese Complexes of N-Substituted Di(picolyl)amineInorganic Chemistry, 2011
- Organometallic Anticancer CompoundsJournal of Medicinal Chemistry, 2010
- Metals in anticancer therapy: Copper(II) complexes as inhibitors of the 20S proteasomeEuropean Journal of Medicinal Chemistry, 2009
- Ni(II), Cu(II), and Zn(II) Diethyldithiocarbamate Complexes Show Various Activities Against the Proteasome in Breast Cancer CellsJournal of Medicinal Chemistry, 2008
- Manganese: Recent advances in understanding its transport and neurotoxicityToxicology and Applied Pharmacology, 2007
- Drug discovery in the ubiquitin–proteasome systemNature Reviews Drug Discovery, 2006
- Inhibition of prostate cancer cellular proteasome activity by a pyrrolidine dithiocarbamate-copper complex is associated with suppression of proliferation and induction of apoptosisFrontiers in Bioscience-Landmark, 2005
- Evaluation of the relative contribution of nitric oxide and peroxynitrite to the suppression of mitochondrial respiration in immunostimulated macrophages using a manganese mesoporphyrin superoxide dismutase mimetic and peroxynitrite scavengerFEBS Letters, 1996